Articles tagged with Cervical Cancer
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
The study estimated that prevention, screening, and treatment efforts in the US led to an average of 8 out of 10 cancer deaths being avoided for breast, cervical, colorectal, lung, and prostate cancers combined. The total number of averted cancer deaths was approximately 5.94 million between 1975 and 2020.
A study published in Nature reveals that dietary fructose promotes tumor growth in animal models of melanoma, breast cancer, and cervical cancer. The liver converts fructose into usable nutrients for cancer cells, a finding that could lead to new treatment avenues.
A series of five papers highlights critical public health challenges related to cancer control in eight SAARC countries and the Rohingya refugee population in Bangladesh. The studies identify barriers contributing to significant disparities in cancer outcomes and actionable solutions to address these challenges.
A significant drop in cervical cancer mortality among US women younger than age 25 has been observed, according to a recent study published in JAMA Network. The findings indicate that widespread HPV vaccination is driving this decline, reducing the prevalence of HPV infection and subsequent cervical cancer incidence.
Researchers at MUSC Hollings Cancer Center found a significant reduction in cervical cancer deaths among young women due to HPV vaccination. The study revealed a 62% decline in mortality rates over the last decade.
The event brings together leading minds in engineering, oncology, and global health to foster collaboration and recognize achievements within CITEC's community. Groundbreaking research and novel point-of-care solutions aimed at transforming cancer detection and treatment worldwide were showcased during the gathering.
A new gold-based compound has been developed that slows tumour growth in animals by 82%, targeting cancers more selectively than standard chemotherapy drugs. It also blocks cancer cells' ability to form new blood vessels, a promising approach to reducing toxic side effects.
A groundbreaking study explores the therapeutic potential of tumor-infiltrating lymphocytes (TILs) derived from metastatic lymph nodes in advanced cervical cancer. The innovative approach demonstrates a manageable safety profile, while also showing promise for improving treatment efficacy.
Ayya Azzahra of CervivAI and Neda Razavi of iSono Health have been named as the two winners of Qatar Foundation's World Innovation Summit for Health (WISH) 2024 Innovation Competitions. The awards include cash prizes and mentoring sessions with leading industry experts.
Researchers developed HPV16 peptide microspheres to induce specific cytotoxic T lymphocytes, leading to tumor regression in cervical cancer models. The approach combines peptide-based vaccinations with microsphere technology to enhance immune responses and eliminate tumor cells.
Researchers have developed a 'mini-protein' that targets cancer cells expressing Nectin-4, allowing for direct delivery of radiation to tumours. The treatment shows promise in targeting multiple types of cancers and has the potential to be safe for repeated administrations.
A new study by Queen Mary University of London found that 85% of women aged 24-65 prefer the option to choose between self-sampling and traditional cervical screening. The study highlights a growing demand for more flexibility and accessible cervical cancer testing options. Women's attitudes towards choice were influenced by factors su...
A new Canadian study models a 1-dose HPV vaccination approach and finds it could prevent a similar number of cervical cancers as 2 doses if vaccine protection remains high. The switch is projected to be a more efficient use of vaccine doses, potentially eliminating cervical cancer in Canada by 2040.
Researchers have found that natural killer cells instinctively recognize and attack the XPO1 protein, which drives cancer growth. By targeting this protein, scientists may be able to activate more killer cells to destroy cancer cells. The study suggests that this approach could lead to personalized cancer treatment with less side effects.
A new Swedish registry study found that girls with mental illness or neurodevelopmental conditions have lower HPV vaccination coverage compared to their peers. The study involved over 115,000 girls and found significant differences in vaccination rates among those with psychiatric diagnoses or receiving psychotropic medications.
A study found that men infected with high-risk types of HPV could experience sperm death from oxidative stress, leading to impaired fertility. The researchers also discovered a weakened local immune response in the urogenital tract, which may contribute to these effects.
A new HPV vaccine has been developed that protects against all cancer-causing HPV types and triggers cellular immune responses to eliminate infected cells. The vaccine's thermal stability and affordability make it an ideal solution for increasing vaccination rates in developing countries.
A clinical trial in Denmark found that offering women further screening opportunities during breast cancer screenings significantly increased their participation and enabled early diagnosis of other cancers. The study used a cluster-randomized crossover design and involved over 27,000 participants.
A research team has identified novel biomarkers in cervical mucus samples that show high diagnostic power for detecting cervical cancer. The findings suggest that analyzing local expression levels may offer a superior diagnostic strategy, potentially reducing the need for invasive procedures.
Cervical cancer is a significant global health issue, with over 443,000 deaths annually projected by 2030. Widespread HPV vaccination and regular screening are crucial in preventing infections and early detection of abnormalities.
A new surgical method developed in Leipzig offers significant benefits over conventional treatment for cervical cancer, with a 9.4% lower recurrence rate after five years. This innovative approach also leads to a 58% lower risk of mortality from the disease.
A new urine-based test accurately measures high-risk HPV16 E7 oncoproteins in urine to detect cervical cancer. The test shows promise in making cervical cancer screening more accessible and less invasive.
A study conducted by Boston University School of Medicine reveals that more than half of healthcare providers would recommend human papillomavirus (HPV) self-collection to their patients if FDA-approved. This technology could help reduce barriers to access and personal medical conditions related to cervical cancer screening.
Past-year Papanicolaou testing rates dropped in 2022 compared to 2019, highlighting the need to increase access to screenings. Rural-vs-urban differences indicate a focus on rural females requires attention.
A new study published in the Journal of Clinical Oncology finds that open radical hysterectomy leads to better survival and lower recurrence rates for early-stage cervical cancer patients. The research, led by Houston Methodist researchers, builds on earlier findings that suggested minimally invasive surgery carries a higher risk of di...
Generation X sees gains in leading cancers, but lower rates of lung and cervical cancers compared to previous generations. Cancer incidence could remain high for decades if current trends continue.
A new molecular test WID-qCIN detects significantly more cancers and precancerous stages than current methods, identifying 100% of invasive cervical cancer and 93% of serious precancerous lesions. The test reduces the need for colposcopy examinations by 40%, improving the effectiveness of screening programs.
A modelling study suggests HPV-based screening could eliminate cervical cancer in British Columbia by 2034, reducing the number of cases from over 90% to zero. The screening method also increases access and uptake, particularly for underscreened populations.
A recent study discovered a unique vaginal microbiome in patients with gynecological cancers, which could serve as a diagnostic biomarker. The researchers found a decrease in beneficial bacteria and an increase in potentially pathogenic microorganisms, leading to promising results for early detection.
A study found that the risk of detecting cervical precancer eight years after a negative HPV screening was similar to the risk after three years after a negative cytology screening. Longer intervals between HPV screens showed lower risk of cervical precancer after six and eight years.
The HPV vaccination programme is helping to close health inequalities in cervical cancer, with most cases prevented in more deprived groups. The study found that the vaccine reduced cervical cancer incidence rates by nearly 90% and pre-cancerous conditions by around 95% in women who received routine vaccination at 12-13 years old.
Researchers discovered that aggressive cancer cells pull more strongly on the extracellular matrix than on themselves, while noninvasive cells pull more strongly on themselves. The study found that the interplay between these contractility modes determines a cell's potential for escape and tumor aggressiveness.
The summit aimed to improve care for people with cancer by discussing knowledge gaps, societal stigma, and shifting policies. Experts emphasized the importance of education about sexual and reproductive health in cancer treatment.
A cross-sectional study in Bangladesh found a low prevalence of high-risk human papillomavirus (HPV) genotypes among women, with significant regional variation. The study revealed higher infection rates in rural areas, particularly in Sylhet and Mymensingh divisions.
The global cervical cancer vaccine roll-out has shown significant effectiveness in reducing HPV-related diseases. However, there are huge variations in coverage between countries, with high-income nations leading the way and many low- and middle-income countries lagging behind. Globally, only 44% of girls have received at least one dos...
The innovative Integrated Virtual Care (IVC) program successfully connected residents with family physicians in Renfrew County, addressing the rural shortage of primary care providers. Over 2,800 unique patient appointments were conducted, with 70% done virtually, offering comprehensive team-based primary care.
Researchers have developed a urine-based test that detects pieces of DNA fragments released by head and neck tumors, providing a non-invasive alternative to traditional blood-based biomarker tests. The test has been shown to detect cancer recurrences far earlier than would typically happen based on clinical imaging.
Researchers have identified new genetic variants linked to susceptibility of cervical cancer-causing virus, raising the risk of getting cervical cancer from high-risk HPV infection. The study found polygenic risk scores to determine likelihood of having prevalent or persistent HPV infections.
Researchers at Mass General Cancer Center presented advancements in rapid nucleic acid detection for cervical cancer screening using CRISPR technology. They also showcased improvements to CAR T cell therapy for pancreatic cancer, highlighting the importance of dynamic functional control to enhance its efficacy.
Low HPV vaccine uptake among US adults aged 27-45 is a concern, particularly for men and Hispanic individuals. Experts stress the need to address disparities in vaccination rates to prevent cancer cases.
A new study suggests that removing barriers to cervical cancer screening, surveillance, and diagnostic procedures can save lives and reduce disparities. If every eligible person gets the full screening and follow-up tests recommended, up to 23% fewer people would be diagnosed with cervical cancer and 20% fewer would die from it.
A study by Cancer Research UK reveals that mortality rates have dropped by 37% in men and 33% in women, with significant reductions in cervical cancer and lung cancer. However, cancer cases are on the rise overall, and researchers warn of an immense challenge ahead to maintain progress.
Researchers at York University found that women with both high-risk human papillomavirus (HPV) and metabolic syndrome are at a significantly higher risk of mortality. The study analyzed data from over 5,000 individuals and found that those with both conditions had a 2.6 times higher risk for mortality than those without either condition.
Researchers developed gene-edited lymphocytes that target HPV-specific antigens in cervical cancer cells, evading immune responses and achieving strong cytotoxicity. These 'off-the-shelf' therapies offer a promising approach to treating cervical cancer.
A new study published in Oncotarget reveals a higher prevalence of germline BRCA1 and BRCA2 mutations in ovarian cancer patients from the Salento peninsula, with 28.6% having familial cases and 39.7% having sporadic cases. The study found that 29.8% of patients were carriers of BRCA1/2 mutation.
Research finds socioeconomically advantaged parents are less likely to vaccinate their teens against HPV due to safety concerns. Parents from disadvantaged groups cite lack of knowledge as a reason for hesitancy.
Researchers discovered that women with high-risk HPV infection have a significantly increased risk of blocked arteries, heart disease, and stroke. The study highlights the importance of monitoring cardiovascular health in patients with high-risk HPV, particularly those with obesity or other risk factors.
Cancer kills more Black people than White individuals in the Barretos region, whereas in São Paulo city, it is the opposite, according to a study published in Cancer Causes & Control. The disparity is most pronounced for breast and cervical cancer among Black women.
Experts predict a significant increase in bowel cancer death rates among young adults in the EU and UK, driven by rising obesity and heavy alcohol consumption. Death rates are predicted to rise by 26% in men and nearly 39% in women in the UK, with similar increases seen in Italy and other European countries.
Studies published in Nature Medicine show that implementing updated WHO screening guidelines could reduce cervical cancer death rates by over 63% in low-to-middle-income countries. Women with HIV have a sixfold risk of developing cervical cancer, and primary HPV testing can save up to 38 women's lives for every 71 screened.
A study of 562,000 women with endometrial, ovarian, or cervical cancer reveals racial and ethnic disparities in clinical trial enrollment. Underrepresented groups face significant barriers to participation, highlighting the need for continued efforts to address these disparities.
Adding immunotherapy atezolizumab to chemotherapy and bevacizumab improved overall survival by 32.1 months compared to 22.8 months with standard therapy alone. The two-year survival rate was also higher, with 60% in patients treated with the experimental combination.
A recent study published in The BMJ suggests that actively monitoring abnormal cells on the cervix rather than removing them immediately may be associated with a higher long-term risk of cervical cancer. Women who underwent active surveillance had a nearly fourfold higher risk of cervical cancer after 20 years compared to those who rec...
A randomized clinical trial of 31,000 individuals found that direct-mail human papillomavirus (HPV) self-sampling increased cervical cancer screening by more than 14%. The study suggests that systems implementing HPV self-sampling should prioritize direct-mail outreach for under-screened individuals to increase screening adherence.
A new study funded by Cancer Research UK reveals that smoking tobacco causes 20.8 million years of life loss each year, with four preventable risk factors contributing to over 30 million years of life lost annually. The study suggests that action on a global scale could save millions of lives from preventable cancers.
A study published in PLOS ONE found that nitrile gloves can effectively prevent the collapse of speculums during pelvic exams, reducing discomfort and misdiagnosis. The researchers used a physical model to test the effectiveness of gloves versus condoms, with promising results.
A study published in Cell Host and Microbe found that gender-neutral HPV vaccination is effective in preventing cervical cancer by inducing a stronger herd immunity. The vaccine protects against high-risk HPV types 16 and 18, which cause 70% of all HPV-related cervical cancers, and also provides cross-protection against low-risk types.
Research by George Mason University found that women with physical disabilities have lower cervical cancer screening rates, highlighting the need for improved access to preventive health services. The study's findings also reveal disparities in screening rates among different types of disabilities.
A team of researchers at Kyoto University has found that a deficiency in the enzyme B4GALT3 inhibits tumor growth in mice. The study shows that reduced glycosylation on T cell surfaces correlates with increased CD8+ immune cells infiltrating tumors.
The INTERLACE trial found that a short course of induction chemotherapy prior to chemoradiation significantly improves survival and reduces recurrence in locally advanced cervical cancer patients. The study results show a 35% reduction in recurrence, with 80% of patients alive and 73% without cancer return or spread after five years.